# EDGAR Filing Document

**Accession Number:** 0000021076
**File Stem:** 0001206774-25-000747
**Filing Date:** 2025-11
**Character Count:** 6288
**Document Hash:** b69003f53229dd219dabd841d2d17a06
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001206774-25-000747.hdr.sgml**: 20251120

**ACCESSION NUMBER**: 0001206774-25-000747

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20251119

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20251120

**DATE AS OF CHANGE**: 20251120

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CLOROX CO /DE/
- **CENTRAL INDEX KEY:** 0000021076
- **STANDARD INDUSTRIAL CLASSIFICATION:** SPECIALTY CLEANING, POLISHING AND SANITATION PREPARATIONS [2842]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 310595760
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-07151
- **FILM NUMBER:** 251503614

**BUSINESS ADDRESS:**
- **STREET 1:** THE CLOROX COMPANY
- **STREET 2:** 1221 BROADWAY
- **CITY:** OAKLAND
- **STATE:** CA
- **ZIP:** 94612-1888
- **BUSINESS PHONE:** 5102717000

**MAIL ADDRESS:**
- **STREET 1:** P.O. BOX 24305
- **CITY:** OAKLAND
- **STATE:** CA
- **ZIP:** 94612-1305

?xml version='1.0' encoding='ASCII'?

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION** **Washington, D.C. 20549** 

**FORM 8-K**

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 19, 2025

![](clx4562621-8k1x1x1.jpg)

THE CLOROX COMPANY

(Exact name of registrant as specified in its charter)

Delaware 1-07151 31-0595760 <br> (State or other jurisdiction of (Commission File Number) (I.R.S. Employer <br> incorporation) Identification No.)

**1221 Broadway, Oakland, California 94612-1888** (Address of principal executive offices) (Zip code)

**(510) 271-7000** (Registrant's telephone number, including area code)

**Not applicable** (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 Under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;**Title of each class** | &nbsp;&nbsp;**Trading<br> Symbol(s)** | **Name of each exchange on which registered** |
| &nbsp;&nbsp;Common Stock - $1.00 par value | &nbsp;&nbsp;CLX | &nbsp;&nbsp;New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 5.07 Submission of Matters to a Vote of Security Holders.**

(a) On November 19, 2025, The Clorox Company (the "Company") held its virtual annual meeting of shareholders.

(b) The shareholders (1) elected all of the Company's nominees for director, (2) approved the compensation of the Company's named executive officers on an advisory basis, and (3) ratified the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2026.

The final voting results on each of the matters submitted to a vote are as follows:

&nbsp;&nbsp;&nbsp;&nbsp;1. Election of Directors:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Number of Votes | Number of Votes | Number of Votes | Number of Votes |
|  | For | Against | Abstain | Broker Non-Votes |
| Gina Boswell | 87241439 | 911643 | 304320 | 16748497 |
| Stephen B. Bratspies | 87311360 | 828040 | 318002 | 16748497 |
| Pierre R. Breber | 86288908 | 1855117 | 313378 | 16748497 |
| Julia Denman | 87349899 | 806877 | 300626 | 16748497 |
| Esther Lee | 84749929 | 3372071 | 335403 | 16748497 |
| A.D. David Mackay | 87066608 | 1080570 | 310224 | 16748497 |
| Stephanie Plaines | 86840639 | 1222967 | 393796 | 16748497 |
| Linda Rendle | 81216339 | 6634729 | 606334 | 16748497 |
| Matthew J. Shattock | 87292871 | 850101 | 314430 | 16748497 |
| Russell J. Weiner | 85462554 | 2668550 | 326299 | 16748497 |
| Christopher J. Williams | 86560378 | 1529347 | 367677 | 16748497 |

---

&nbsp;&nbsp;&nbsp;&nbsp;2. Advisory Vote on the Approval of Named Executive Officers Compensation:

---

| | | | |
|:---|:---|:---|:---|
| Number of Votes | Number of Votes | Number of Votes | Number of Votes |
| For | Against | Abstain | Broker Non-Votes |
| 79985792 | 7577339 | 894271 | 16748497 |

---

&nbsp;&nbsp;&nbsp;&nbsp;3. Ratification of the selection of Ernst & Young LLP as the
Company's independent auditor for 2026.

---

| | | | |
|:---|:---|:---|:---|
| Number of Votes | Number of Votes | Number of Votes | Number of Votes |
| For | Against | Abstain | Broker Non-Votes |
| 99330452 | 5516058 | 359389 | 0 |

---

**Item 9.01 Financial Statements and Exhibits**

**(d) Exhibits**

See the Exhibit Index below.

**EXHIBIT INDEX**

---

| | |
|:---|:---|
| **Exhibit** | **Description** |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  |  | THE CLOROX COMPANY | THE CLOROX COMPANY |
| Date: | November 20, 2025 | By: | /s/ Angela Hilt |
|  |  |  | Angela Hilt |
|  |  |  | Executive Vice President - Chief Legal and External Affairs Officer<br> and Corporate Secretary |

---